2,593
Views
44
CrossRef citations to date
0
Altmetric
Research Article

Abnormal expression of long noncoding RNA FGD5-AS1 affects the development of periodontitis through regulating miR-142-3p/SOCS6/NF-κB pathway

, , &
Pages 2098-2106 | Received 03 Apr 2019, Accepted 08 May 2019, Published online: 30 May 2019

References

  • Hajishengallis G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol. 2014;35:3–11.
  • Ratheesh V, Subramanian S, Prakash PSG, et al. Evaluation of association of vitamin D receptor genetic polymorphism with severe CP in an ethnic Tamilian population. Genet Test Mol Biomarkers. 2018;22:615–621.
  • Eberhard J, Jepsen S, Jervøe‐Storm PM, et al. Full‐mouth treatment modalities (within 24 hours) for CP in adults. Cochrane Database Syst Rev. 2015;4:CD004622.
  • Genco RJ, Van Dyke TE. Prevention: reducing the risk of CVD in patients with periodontitis. Nat Rev Cardiol. 2010;7:479–480.
  • Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol. 2011;7:738–748.
  • Madianos PN, Bobetsis YA, Offenbacher S. Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms. J Clin Periodontol. 2013;40:S170–S180.
  • Kanduri C. Long noncoding RNAs: Lessons from genomic imprinting. Biochim Biophys Acta. 2016;1859:102–111.
  • Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152:1298–1307.
  • Iyer MK, Niknafs YS, Malik R, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47:199.
  • Zou Y, Li C, Shu F, et al. lncRNA expression signatures in periodontitis revealed by microarray: the potential role of lncRNAs in periodontitis pathogenesis. J Cell Biochem. 2015;116:640–647.
  • Li S, Liu X, Li H, et al. Integrated analysis of long noncoding RNA-associated competing endogenous RNA network in periodontitis. J Periodont Res. 2018;53:495–505.
  • Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353–358.
  • Qi X, Zhang D, Wu N, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52:710–718.
  • Du H, Chen Y. Competing endogenous RNA networks in cervical cancer: function, mechanism, and perspective. J Drug Target. 2018;1–47.
  • Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693–733.
  • Zhang H, Sun SC. NF-κB in inflammation and renal diseases. Cell Biosci. 2015;5:63
  • Li C, Yue J, Huang X, et al. miR-21 and miR-101 regulate PLAP-1 expression in periodontal ligament cells. Mol Med Rep. 2012;5:1340.
  • Moffatt CE, Lamont RJ. Porphyromonas gingivalis induction of microRNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells. Infect Immun. 2011;79:2632–2637.
  • Sanders KA, Benton MC, Lea RA, et al. Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells. Clin Epigenet. 2016;8:87–96.
  • Qi X, Li J, Zhou C, et al. MiR-142-3p suppresses SOCS6 expression and promotes cell proliferation in nasopharyngeal carcinoma. Cell Physiol Biochem. 2015;36:1743–1752.
  • Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77:3965–3981.
  • Delás MJ, Hannon GJ. lncRNAs in development and disease: from functions to mechanisms. Open Biol. 2017;7:170121.
  • Simion V, Haemmig S, Feinberg MW. LncRNAs in vascular biology and disease. Vascul Pharmacol. 2019;114:145–156.
  • Xu J, Xu Y. The lncRNA MEG3 downregulation leads to osteoarthritis progression via miR-16/SMAD7 axis. Cell Biosci. 2017;7:69.
  • Dai L, Zhang G, Cheng Z, et al. Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury. Connect Tissue Res. 2018;59:581–592.
  • Yuan Z, Luo G, Li X, et al. PPARγ inhibits HMGB1 expression through upregulation of miR-142-3p in vitro and in vivo. Cell Signal. 2016;28:158–164.
  • Xu G, Zhang Z, Wei J, et al. microR-142-3p down-regulates IRAK-1 in response to Mycobacterium bovis BCG infection in macrophages. Tuberculosis. 2013;93:606–611.
  • Boomiraj H, Mohankumar V, Lalitha P, et al. Human corneal MicroRNA expression profile in fungal keratitis. Invest Ophthalmol Vis Sci. 2015;56:7939.
  • Pivarcsi A, Meisgen F, Xu N, et al. Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy. Br J Dermatol. 2013;169:563–570.
  • Schaefer JS, Attumi T, Opekun AR, et al. MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis. BMC Immunol. 2015;16:5.
  • Wang X, Guo Y, Wang C, et al. MicroRNA-142-3p inhibits chondrocyte apoptosis and inflammation in osteoarthritis by targeting HMGB1. Inflammation. 2016;39:1718–1728.
  • Ulrik R, Lise L, Thomas L, et al. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma. Anticancer Res. 2014;34:7207–7217.
  • Perri R, Nares S, Zhang S, et al. MicroRNA modulation in obesity and periodontitis. J Dent Res. 2012;91:33–38.
  • Duncan SA, Baganizi DR, Sahu R, et al. SOCS proteins as regulators of inflammatory responses induced by bacterial infections: a review. Front Microbiol. 2017;8:2431.
  • Liu Z, Xie D, Zhang H. Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis. Cell Death Dis. 2018;9:1042.
  • Kabir NN, Sun J, Rönnstrand L, et al. SOCS6 is a selective suppressor of receptor tyrosine kinase signaling. Tumor Biol. 2014;35:10581–10589.
  • Yuan D, Wang W, Su J, et al. SOCS6 functions as a tumor suppressor by inducing apoptosis and inhibiting angiogenesis in human prostate cancer. Curr Cancer Drug Targets. 2018;18:894–904.
  • Cheng L, Kong B, Zhao Y, et al. miR-494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expression. Oncol Lett. 2018;15:3075–3080.
  • Nichols TC, Fischer TH, Deliargyris EN, et al. Role of nuclear factor‐kappa B (NF‐κB) in inflammation, periodontitis, and atherogenesis. Ann Periodontol. 2001;6:20–29.
  • Nakajima Y, Furuichi Y, Biswas KK, et al. Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. FEBS Lett. 2006;580:613–619.